Hanauer JR et al.Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors.Mol Ther Oncolytics 3:16003 (2016).
Stewart CE et al.Inhibitors of the interferon response enhance virus replication in vitro.PLoS One 9:e112014 (2014).
Noll M et al.Primary resistance phenomena to oncolytic measles vaccine viruses.Int J Oncol 43:103-12 (2013).
Berchtold S et al.Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.J Virol 87:3484-501 (2013).
Lampe J et al.An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.Gene Ther N/A:N/A (2013).
Mühlebach MD et al.Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus.Cancer Res 70:7620-9 (2010).
Shi W et al.A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions.J Virol 82:6190-9 (2008).